ES2195021T3 - Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis. - Google Patents

Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis.

Info

Publication number
ES2195021T3
ES2195021T3 ES96939325T ES96939325T ES2195021T3 ES 2195021 T3 ES2195021 T3 ES 2195021T3 ES 96939325 T ES96939325 T ES 96939325T ES 96939325 T ES96939325 T ES 96939325T ES 2195021 T3 ES2195021 T3 ES 2195021T3
Authority
ES
Spain
Prior art keywords
urolitiasis
favor
medication
calculations
elimination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96939325T
Other languages
English (en)
Inventor
Masuo Akahane
Yoshitaka Tomiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2195021T3 publication Critical patent/ES2195021T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE UN NUEVO FARMACO PARA ALIVIAR EL DOLOR Y PARA ESTIMULAR LA ELIMINACION DE CALCULOS EN UROLITIASIS, QUE CONTIENE COMO PRINCIPIO ACTIVO UN FARMACO QUE PRESENTA EFECTOS ESTIMULANTES EN LOS ADRENOCEPTORES BE 2 Y BE 3 , Y QUE EJERCE UN POTENTE EFECTO RELAJANTE SOBRE EL MUSCULO LISO URETRAL HUMANO.
ES96939325T 1995-11-30 1996-11-29 Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis. Expired - Lifetime ES2195021T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34659995 1995-11-30

Publications (1)

Publication Number Publication Date
ES2195021T3 true ES2195021T3 (es) 2003-12-01

Family

ID=18384525

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96939325T Expired - Lifetime ES2195021T3 (es) 1995-11-30 1996-11-29 Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis.

Country Status (10)

Country Link
US (2) US6410560B1 (es)
EP (1) EP0872246B1 (es)
KR (1) KR19990071800A (es)
AT (1) ATE232740T1 (es)
AU (1) AU7639796A (es)
DE (1) DE69626312T2 (es)
DK (1) DK0872246T3 (es)
ES (1) ES2195021T3 (es)
PT (1) PT872246E (es)
WO (1) WO1997019700A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID24062A (id) * 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
US20040097996A1 (en) 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
WO2007061114A1 (ja) * 2005-11-28 2007-05-31 Kissei Pharmaceutical Co., Ltd. 神経因性疼痛の予防又は治療用医薬組成物
US10267796B2 (en) * 2010-10-25 2019-04-23 The Procter & Gamble Company Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25150A (en) * 1986-06-05 1991-03-13 Ciba Geigy Ag Novel pharmaceutical preparation for topical application

Also Published As

Publication number Publication date
ATE232740T1 (de) 2003-03-15
EP0872246A4 (en) 1999-03-24
WO1997019700A1 (fr) 1997-06-05
US6410560B1 (en) 2002-06-25
EP0872246A1 (en) 1998-10-21
DE69626312D1 (de) 2003-03-27
AU7639796A (en) 1997-06-19
EP0872246B1 (en) 2003-02-19
US6376513B1 (en) 2002-04-23
DK0872246T3 (da) 2003-06-10
DE69626312T2 (de) 2004-01-22
PT872246E (pt) 2003-07-31
KR19990071800A (ko) 1999-09-27

Similar Documents

Publication Publication Date Title
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
CA2025078A1 (en) External Analgesic lotion and Method of Making
ES2165910T3 (es) Administracion nasal y ocular de cetamina para el tratamiento del dolor y para la desintoxicacion.
HUP0203198A2 (hu) Tramadolvegyület és görcsoldó hatóanyagot tartalmazó gyógyászati készítmény, eljárás az előállítására és alkalmazása
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
ES2165990T3 (es) Thip para el tratamiento de trastornos del sueño.
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
CA2154103A1 (en) Treatment of Mucous Membrane Disease, Trauma or Condition and for the Relief of Pain
RU95103892A (ru) Композиция топического нанесения для стимулирования роста волос и/или замедления их выпадения, способ косметического лечения волос, применение производного альфа -пирона для получения композиции
IT1212041B (it) Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
ES2195021T3 (es) Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis.
WO1998025573A3 (en) The use of celastrol to treat alzheimer's disease
EP0744176A3 (en) Methods for inhibiting bone loss
CA2319542A1 (en) The treatment of sexual dysfunction in certain patient groups
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
KR930021178A (ko) 뼈 형성을 자극하는 약제
DE69510933D1 (de) Amidderivate und ihre therapeutische anwendung
CA2238621A1 (en) Novel drug for relieving pain and promoting the removal of calculi in urolithiasis
AU2143892A (en) Use of formoterol for treatment of tissue injury
CA2145211A1 (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
ES1031861Y (es) Dispositivo terapeutico para el alivio del dolor menstrual.
FR2736548B1 (fr) Utilisation d'un retinoide pour la preparation d'un medicament antibacterien et methode de traitement cosmetique
AU7254494A (en) 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain
MD1469G2 (ro) Metodă de tratament al şocului combustional